Avisa Myko
Natural melanin for UV and radiation protection
San Francisco, United States · Founded 2019 · $2.9M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- avisamyko.com
- Total Funding
- $2.9M
- Last Round
- $2.5M SeedAug 2023
- Rounds
- 2
About
Avisa Myko produces natural soluble melanin at significantly lower cost than existing methods, targeting UV and radiation protection applications in cosmetics, biomedicine, and energy sectors. The company is backed by SOSV and Indiebio and is developing the world's first melanin-based SPF 30 biodegradable sunscreen, among other applications in clean energy and health protection.
Summary
Avisa Myko is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $2.9M in total across 2 rounds, most recently a $2.5M Seed round in Aug 2023. Investors include SOSV and IndieBio.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...